Dr. Adam Wilk of the Rollins School of Public Health and Dr. David Prologo of Emory John’s Creek Hospital

This week, we’re joined by Dr. Adam Wilk of the Rollins School of Public Health, who will discuss the Affordable Care Act — and Dr. David Prologo of Emory John’s Creek Hospital, who will discuss the opioid epidemic.

Adam Wilk of the Rollins School of Public Health

Adam Wilk is an assistant professor in the Department of Health Policy and Management. He is a health economist and health services researcher, conducting research on physician decision-making — both clinical and organizational — Medicaid and underserved populations, and the management of complex, chronically ill patients, particularly patients with end-stage renal disease undergoing dialysis. Other research interests include medical consultations in inpatient care and geographic variation in utilization, costs, and quality.

Dr. Wilk received his doctorate at The University of Michigan School of Public Health in 2015. Before his time in Michigan, Dr. Wilk worked to develop episode-based cost-of-care measures at The Brookings Institution and as a consultant to state Medicaid agencies and private insurers at The Lewin Group.

Dr. David Prologo of Emory John’s Creek Hospital

Dr. Prologo is an interventional radiologist whose research has focused on the application of image guided techniques to the delivery of stem cell therapies, the treatment of cancer pain, and for obesity management. He is a nationally recognized expert in ablative therapies and has pioneered several new procedures in the subspecialty – including the cryoablation of nerves.

Dr. Prologo also has Obesity Medicine Board certification (since 2016).